Dentists in Lexington, MS Accepting Medicare

6 Dentists found. Showing 1 - 6

Mr. Charles D Howard, DMD Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 102 Wall St, Lexington, MS 39095 Phone: 662-834-1585    Fax: 662-834-1583

Dr. Heather Killebrew Tutor, DMD Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 102 Carrollton Ave, Lexington, MS 39095 Phone: 662-834-9899    Fax: 662-834-9895

Dr. Laura Dixon, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 302 Court Square, Lexington, MS 39095 Phone: 662-834-9899    Fax: 662-834-9895

Samuel Reid Lester, DMD Dentist Medicare: Medicare Enrolled Practice Location: 102 Carrollton Ave, Lexington, MS 39095 Phone: 662-834-9899

Dr. Dustin Pambianchi, DMD Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 302 Court Sq, Lexington, MS 39095 Phone: 662-834-9899

Dr. Skyler Edward Myers, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 302 Court Sq, Lexington, MS 39095 Phone: 662-834-9899

News Archive

TaiGen, R-Pharm sign exclusive agreement to develop and commercialize nemonoxacin

TaiGen Biotechnology Company, Limited today announced that they have signed an exclusive agreement with R-Pharm, a leading Russian pharmaceutical company, to develop and commercialize nemonoxacin (Taigexyn) in the Russian Federation, Turkey and other members of the Commonwealth Independent States.

Older patients with acute myeloid leukemia may benefit from decitabine drug

Older patients with acute myeloid leukemia (AML) might benefit from a drug that reactivates genes that cancer cells turn off, according to research at Washington University School of Medicine in St. Louis and collaborating institutions.

Synthetic, Enterome partner to study effects of beta-lactam antibiotics on gastrointestinal microflora

Synthetic Biologics, Inc., a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, and Enterome Bioscience SA, a pioneer in the development of innovative disease management solutions based on a deep understanding of the gut microbiome, today announced that they have entered into an agreement to conduct metagenomic research on the effects of beta-lactam antibiotics on the gastrointestinal microflora (microbiome) of human patients.

Cysteamine inhibits SARS-CoV-2 variants of concern in vitro

Researchers in the United States have shown that a compound currently used to treat cystinosis exhibits broad antiviral activity against variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

First U.S. facial transplantation procedure: Functional, psychological, and social outcome excellent

Detailed information on the first facial transplantation procedure performed in the United States is presented in the January issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS). The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy.

Read more Medical News

› Verified 9 days ago